Does obesity cause leukocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, obesity can cause leukocytosis, which is an elevated white blood cell count, due to the chronic low-grade inflammation triggered by adipose tissue producing inflammatory cytokines and adipokines. This relationship occurs because adipose tissue (fat) is not just an energy storage site but also an active endocrine organ that produces these substances, stimulating the bone marrow to produce more white blood cells 1. The degree of leukocytosis often correlates with the severity of obesity, with higher BMIs associated with higher white blood cell counts.

Key Points to Consider

  • Obesity is a chronic disease that requires effective prevention and treatment, and its management should consider its impact on various bodily systems, including the hematologic system 1.
  • The inflammatory state contributed by obesity leads to many complications, including insulin resistance, type 2 diabetes, and cardiovascular disease 1.
  • When evaluating leukocytosis in an obese patient, clinicians should consider obesity as a potential cause while still ruling out other etiologies such as infection, stress, medication effects, or underlying hematologic disorders.
  • Weight loss through diet, exercise, or bariatric surgery can reduce this inflammatory response and normalize white blood cell counts over time, as evidenced by decreases in plasma CRP concentration and other inflammatory markers with weight reduction 1.

Clinical Implications

  • Recognizing obesity as a disease rather than just a risk factor for other conditions is crucial for its management and for reducing the stigma associated with weight issues 1.
  • The management of obesity should be multifaceted, addressing behavioral, nutritional, and physical activity aspects, among others, to effectively reduce disease risk factors and improve outcomes 1.
  • Clinicians should be aware of the latest guidelines and evidence-based practices in obesity management to provide the best care for their patients.

From the Research

Obesity and Leukocytosis

  • Obesity is recognized as a state of low-grade inflammation, which can lead to an increase in white blood cell count, including leukocytosis 2, 3, 4.
  • Studies have shown that obese individuals have higher levels of inflammatory cytokines, such as C-reactive protein (CRP), interleukin 6 (IL-6), and tumoral necrosis factor alpha (TNF-alpha), which can contribute to leukocytosis 2, 5.
  • The relationship between obesity and leukocytosis has been observed in various studies, with some showing a positive correlation between body mass index (BMI) and leukocyte count 2, 6.
  • Leukocytosis in obese individuals may be due to the production of inflammatory cytokines by adipose tissue, which can lead to an increase in neutrophil and lymphocyte counts 2, 3.

Mechanisms and Associations

  • The chronic inflammatory response in obesity is thought to originate from the links between adipose tissue and the immune system, leading to an altered immune function and increased leukocyte counts 3.
  • Visceral adipose tissue and central obesity may have a greater impact on the inflammatory process and leukocytosis than total body fat 3.
  • Moderate weight loss may not ameliorate the inflammatory state and leukocytosis in the short term, suggesting that other factors may be involved in the development of leukocytosis in obesity 5.
  • Recognizing the association between obesity and leukocytosis may help clinicians avoid unnecessary diagnostic work-up and provide reassurance regarding otherwise unexplained hematologic abnormalities in obese individuals 2, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Obesity, inflammation and the immune system.

The Proceedings of the Nutrition Society, 2012

Research

The hematologic consequences of obesity.

European journal of haematology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.